CSWYY (China Shineway Pharmaceutical Group) YoY EBITDA Growth: 78.24% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
88 GF Score
Price $19.25
GF Value $15.61
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group YoY EBITDA Growth?

China Shineway Pharmaceutical Group CSWYY 88 YoY EBITDA Growth is 78.24% as of Dec. 2025. GuruFocus rates CSWYY with a GF Score™ of 88/100 and a GF Value™ of $15.61. The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. China Shineway Pharmaceutical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 78.24%.

China Shineway Pharmaceutical Group's EBITDA per Share for the six months ended in Dec. 2025 was $1.86.

China Shineway Pharmaceutical Group YoY EBITDA Growth Related Terms

China Shineway Pharmaceutical Group YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for China Shineway Pharmaceutical Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group YoY EBITDA Growth Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.96 11.52 15.29 -8.13 13.97

China Shineway Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 27.20 -50.78 -8.84 78.24
CSWYY
88GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Shineway Pharmaceutical Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

China Shineway Pharmaceutical Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(5.059-4.439)/ | 4.439 |
=13.97 %

China Shineway Pharmaceutical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(1.859-1.043)/ | 1.043 |
=78.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 78.24% mean?
China Shineway Pharmaceutical Group (CSWYY) has a YoY EBITDA Growth of 78.24% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Shineway Pharmaceutical Group and its competitors.
Is China Shineway Pharmaceutical Group's YoY EBITDA Growth too high?
China Shineway Pharmaceutical Group's current YoY EBITDA Growth is 78.24%. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's YoY EBITDA Growth compare to ZTS?
China Shineway Pharmaceutical Group's YoY EBITDA Growth of 78.24% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current YoY EBITDA Growth is 78.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current YoY EBITDA Growth of 78.24%. The stock's GF Value™ is $15.61, compared to a current price of $19.25 — trading 23.3% above its estimated fair value. The current YoY EBITDA Growth is 78.24%. China Shineway Pharmaceutical Group's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current YoY EBITDA Growth is 78.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 23.3% above its estimated GF Value™ of $15.61.

Key valuation signals for CSWYY:

  • YoY EBITDA Growth: 78.24%
  • GF Value™: $15.61 vs. price of $19.25 (23.3% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
88GF Score

Get the complete analysis for CSWYY

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$15.61
GF Value